Literature DB >> 22265422

SnapShot: Bioactive lysophospholipids.

Wouter H Moolenaar1, Timothy Hla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22265422      PMCID： PMC3645273          DOI： 10.1016/j.cell.2012.01.013

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  10 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 3.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

4.  LPA-producing enzyme PA-PLA₁α regulates hair follicle development by modulating EGFR signalling.

Authors:  Asuka Inoue; Naoaki Arima; Jun Ishiguro; Glenn D Prestwich; Hiroyuki Arai; Junken Aoki
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

5.  The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors.

Authors:  Atsuo Kawahara; Tsuyoshi Nishi; Yu Hisano; Hajime Fukui; Akihito Yamaguchi; Naoki Mochizuki
Journal:  Science       Date:  2008-12-11       Impact factor: 47.728

Review 6.  The alliance of sphingosine-1-phosphate and its receptors in immunity.

Authors:  Juan Rivera; Richard L Proia; Ana Olivera
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

7.  Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.

Authors:  Laurens A van Meeteren; Floor Frederiks; Ben N G Giepmans; Matheus F Fernandes Pedrosa; Stephen J Billington; B Helen Jost; Denise V Tambourgi; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

8.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

9.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

10.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.

Authors:  Hidenobu Kanda; Rebecca Newton; Russell Klein; Yuka Morita; Michael D Gunn; Steven D Rosen
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606
  10 in total
  19 in total

1.  Lysophosphatidic acid and cardiovascular disease: seeing is believing.

Authors:  Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

Review 2.  Lysophospholipid mediators in the vasculature.

Authors:  Paul Mueller; Shaojing Ye; Andrew Morris; Susan S Smyth
Journal:  Exp Cell Res       Date:  2015-03-28       Impact factor: 3.905

3.  Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.

Authors:  Sacha Flammier; Olivier Peyruchaud; Fanny Bourguillault; François Duboeuf; Jean-Luc Davignon; Derek D Norman; Sylvie Isaac; Hubert Marotte; Gabor Tigyi; Irma Machuca-Gayet; Fabienne Coury
Journal:  Arthritis Rheumatol       Date:  2019-09-30       Impact factor: 10.995

4.  Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.

Authors:  Raphael Leblanc; Sue-Chin Lee; Marion David; Jean-Claude Bordet; Derek D Norman; Renukadevi Patil; Duane Miller; Debashish Sahay; Johnny Ribeiro; Philippe Clézardin; Gabor J Tigyi; Olivier Peyruchaud
Journal:  Blood       Date:  2014-10-02       Impact factor: 22.113

5.  Comprehensive and quantitative analysis of lysophospholipid molecular species present in obese mouse liver by shotgun lipidomics.

Authors:  Chunyan Wang; Miao Wang; Xianlin Han
Journal:  Anal Chem       Date:  2015-04-22       Impact factor: 6.986

6.  LPA receptor 4 deficiency attenuates experimental atherosclerosis.

Authors:  Liping Yang; Maria Kraemer; Xianjun Frank Fang; Peggi M Angel; Richard R Drake; Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2019-02-22       Impact factor: 5.922

7.  Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

8.  Lysophospholipids and their G protein-coupled receptors in atherosclerosis.

Authors:  Ya-Feng Li; Rong-Shan Li; Sonia B Samuel; Ramon Cueto; Xin-Yuan Li; Hong Wang; Xiao-Feng Yang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

Review 9.  S1P control of endothelial integrity.

Authors:  Yuquan Xiong; Timothy Hla
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 10.  Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

Authors:  Susan S Smyth; Paul Mueller; Fanmuyi Yang; J Anthony Brandon; Andrew J Morris
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-30       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.